AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 1-25/55
Papillary renal cell carcinoma: Analysis of germline mutations in the MET proto-oncogene in a clinic-based population
Authors: Lindor, NM Dechet, CB Greene, MH Jenkins, RB Zincke, MT Weaver, AL Wilson, M Zincke, H Liu, WG
Citation: Nm. Lindor et al., Papillary renal cell carcinoma: Analysis of germline mutations in the MET proto-oncogene in a clinic-based population, GENET TEST, 5(2), 2001, pp. 101-106
Update on tuberous sclerosis complex
Authors: Torres, VE King, BF McKusick, MA Bjornsson, J Zincke, H
Citation: Ve. Torres et al., Update on tuberous sclerosis complex, CONTR NEPHR, 136, 2001, pp. 33-49
Transitional cell carcinoma of the bladder mimicking recurrent Paget's disease of the vulva: Report of two gases, with one occurring in a myocutaneous flap
Authors: Boardman, CH Webb, MJ Cheville, JC Lerner, SE Zincke, H
Citation: Ch. Boardman et al., Transitional cell carcinoma of the bladder mimicking recurrent Paget's disease of the vulva: Report of two gases, with one occurring in a myocutaneous flap, GYNECOL ONC, 82(1), 2001, pp. 200-204
Lymph node-positive prostate cancer: Evaluation of the results of the combination of androgen deprivation therapy and radiation therapy
Authors: Buskirk, SJ Pisansky, TM Atkinson, EJ Schild, SE O'Brien, PC Wolfe, JT Zincke, H
Citation: Sj. Buskirk et al., Lymph node-positive prostate cancer: Evaluation of the results of the combination of androgen deprivation therapy and radiation therapy, MAYO CLIN P, 76(7), 2001, pp. 702-706
PSA doubling time as a predictor of clinical progression after biochemicalfailure following radical prostatectomy for prostate cancer
Authors: Roberts, SG Blute, ML Bergstralh, EJ Slezak, JM Zincke, H
Citation: Sg. Roberts et al., PSA doubling time as a predictor of clinical progression after biochemicalfailure following radical prostatectomy for prostate cancer, MAYO CLIN P, 76(6), 2001, pp. 576-581
Decline in bilateral orchiectomy for prostate cancer in Olmsted County, Minnesota, 1956-2000
Authors: Melton, LJ Alothman, KI Achenbach, SJ O'Fallon, WM Zincke, H
Citation: Lj. Melton et al., Decline in bilateral orchiectomy for prostate cancer in Olmsted County, Minnesota, 1956-2000, MAYO CLIN P, 76(12), 2001, pp. 1199-1203
Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer
Authors: Zincke, H Lau, W Bergstralh, E Blute, ML
Citation: H. Zincke et al., Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer, J UROL, 166(6), 2001, pp. 2208-2215
Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: Differences in outcome between primary Gleason grades 3 and 4
Authors: Lau, WK Blute, ML Bostwick, DG Weaver, AL Sebo, TJ Zincke, H
Citation: Wk. Lau et al., Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: Differences in outcome between primary Gleason grades 3 and 4, J UROL, 166(5), 2001, pp. 1692-1697
Stage pT1 conventional (clear cell) renal cell carcinoma: Pathological features associated with cancer specific survival
Authors: Cheville, JC Blute, ML Zincke, H Lohse, CM Weaver, AL
Citation: Jc. Cheville et al., Stage pT1 conventional (clear cell) renal cell carcinoma: Pathological features associated with cancer specific survival, J UROL, 166(2), 2001, pp. 453-456
Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?
Authors: Amling, CL Bergstralh, EJ Blute, ML Slezak, JM Zincke, H
Citation: Cl. Amling et al., Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?, J UROL, 165(4), 2001, pp. 1146-1151
Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy
Authors: Blute, ML Bergstralh, EJ Iocca, A Scherer, B Zincke, H
Citation: Ml. Blute et al., Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy, J UROL, 165(1), 2001, pp. 119-125
Pathologic staging of renal cell carcinoma - Significance of tumor classification with the 1997 TNM staging system
Authors: Gettman, MT Blute, ML Spotts, B Bryant, SC Zincke, H
Citation: Mt. Gettman et al., Pathologic staging of renal cell carcinoma - Significance of tumor classification with the 1997 TNM staging system, CANCER, 91(2), 2001, pp. 354-361
Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management - A retrospective analysis
Authors: Barry, MJ Albertsen, PC Bagshaw, MA Blute, ML Cox, R Middleton, RG Gleason, DF Zincke, H Bergstralh, EJ Jacobsen, SJ
Citation: Mj. Barry et al., Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management - A retrospective analysis, CANCER, 91(12), 2001, pp. 2302-2314
Predicting prostate carcinoma volume and stage at radical prostatectomy byassessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen - A report of 454 cases
Authors: Sebo, TJ Cheville, JC Riehle, DL Lohse, CM Pankratz, VS Myers, RP Blute, ML Zincke, H
Citation: Tj. Sebo et al., Predicting prostate carcinoma volume and stage at radical prostatectomy byassessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen - A report of 454 cases, CANCER, 91(11), 2001, pp. 2196-2204
Risk of prostate carcinoma death in patients with lymph node metastasis
Authors: Cheng, L Zincke, H Blute, ML Bergstralh, EJ Scherer, D Bostwick, DG
Citation: L. Cheng et al., Risk of prostate carcinoma death in patients with lymph node metastasis, CANC CYTOP, 91(1), 2001, pp. 66-73
Risk of prostate carcinoma death in patients with lymph node metastasis
Authors: Cheng, L Zincke, H Blute, ML Bergstralh, EJ Scherer, B Bostwick, DG
Citation: L. Cheng et al., Risk of prostate carcinoma death in patients with lymph node metastasis, CANCER, 91(1), 2001, pp. 66-73
Grading and staging of bladder carcinoma in transurethral resection specimens - Correlation with 105 matched cystectomy specimens
Authors: Cheng, L Neumann, RM Weaver, AL Cheville, JC Leibovich, BC Ramnani, DM Scherer, BG Nehra, A Zincke, H Bostwick, DG
Citation: L. Cheng et al., Grading and staging of bladder carcinoma in transurethral resection specimens - Correlation with 105 matched cystectomy specimens, AM J CLIN P, 113(2), 2000, pp. 275-279
The cell cycle inhibitors p21(WAF1) and p27(KIP1) are associated with survival in patients treated by salvage prostatectomy after radiation therapy
Authors: Cheng, L Lloyd, RV Weaver, AL Pisansky, TM Cheville, JC Ramnani, DM Leibovich, BC Blute, ML Zincke, H Bostwick, DG
Citation: L. Cheng et al., The cell cycle inhibitors p21(WAF1) and p27(KIP1) are associated with survival in patients treated by salvage prostatectomy after radiation therapy, CLIN CANC R, 6(5), 2000, pp. 1896-1899
Extranodal extension in lymph node-positive prostate cancer
Authors: Cheng, L Pisansky, TM Ramnani, DM Leibovich, BC Cheville, JC Slezak, E Bergstralh, EJ Zincke, H Bostwick, DG
Citation: L. Cheng et al., Extranodal extension in lymph node-positive prostate cancer, MOD PATHOL, 13(2), 2000, pp. 113-118
Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy
Authors: Cheng, L Slezak, J Bergstralh, EJ Myers, RP Zincke, H Bostwick, DG
Citation: L. Cheng et al., Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy, J CL ONCOL, 18(15), 2000, pp. 2862-2868
Proximity of prostate cancer to the urethra: Implications for minimally invasive ablative therapies
Authors: Leibovich, BC Blute, ML Bostwick, DG Wilson, TM Pisansky, TM Davis, BJ Ramnani, DM Cheng, L Sebo, TJ Zincke, H
Citation: Bc. Leibovich et al., Proximity of prostate cancer to the urethra: Implications for minimally invasive ablative therapies, UROLOGY, 56(5), 2000, pp. 726-729
Renal cell carcinoma metastatic to the pancreas: Clinical and radiologicalfeatures
Authors: Ghavamian, R Klein, KA Stephens, DH Welch, TJ LeRoy, AJ Richardson, RL Burch, PA Zincke, H
Citation: R. Ghavamian et al., Renal cell carcinoma metastatic to the pancreas: Clinical and radiologicalfeatures, MAYO CLIN P, 75(6), 2000, pp. 581-585
Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney
Authors: Lau, WKO Blute, ML Weaver, AL Torres, VE Zincke, H
Citation: Wko. Lau et al., Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney, MAYO CLIN P, 75(12), 2000, pp. 1236-1242
Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease
Authors: Blute, ML Amling, CL Bryant, SC Zincke, H
Citation: Ml. Blute et al., Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease, MAYO CLIN P, 75(10), 2000, pp. 1020-1026
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer
Authors: Blute, ML Bergstralh, EJ Partin, AW Walsh, PC Kattan, MW Scardino, PT Montie, JE Pearson, JD Slezak, JM Zincke, H
Citation: Ml. Blute et al., Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer, J UROL, 164(5), 2000, pp. 1591-1595
Risultati: 1-25 | 26-50 | 51-55